Novavax Inc. closed 73.09% below its 52-week high of $23.86, which the company achieved on June 6th.

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Shares of Novavax Inc. NVAX shed 5.66% to $6.67 Friday, on what proved to be an all-around positive trading session for the ...

BofA notes that Novavax (NVAX) shares are up 21% after announcing the company has received communication from the FDA for a post marketing ...

Novavax (NVAX) issued the following update on the FDA BLA for the company’s COVID-19 vaccine: “We believe that our Biologics License ...

WASHINGTON — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the ...

A company in Canada is recalling ham sandwiches after government testing showed Listeria monocytogenes. The Canadian Food Inspection Agency reports that Cuisine Fraicheur Urbaine brand Black ...